by John A. Jenkins | Aug 5, 2026 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Stock Market
FOIAengine: Requests from Point72, Sofinnova, Holocene, Triple Gate and Others A review of the latest Freedom of Information Act requests targeting three life-sciences companies – Novo Nordisk (NYSE: NVO); Charles River Laboratories (NYSE: CRL); and iRhythm...
by John A. Jenkins | Jun 17, 2026 | FOIA, Hedge Funds, SEC, Short-Selling, Stock Market
FOIA Requests Offer Signals, and a Requester Provides Names Activist short seller Andrew Left always had a taste for risk. So, with his freedom and fortune on the line a few weeks ago in a Los Angeles courtroom, Left tried to beat the federal securities fraud charges...
by Randy Miller | May 6, 2026 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine: Assessments Include Operational, Clinical and Commercial Threats Freedom of Information Act requests to the Food and Drug Administration during March illustrated three of the primary uncertainties facing U.S. drug manufacturers and their investors: the...
by John A. Jenkins | Sep 3, 2025 | FOIA, Hedge Funds, News Media, Politics, SEC
FOIAengine: Wall Street Journal Seeking SEC Emails and Texts Involving the Trump-Affiliated Venture Capital Firm The Wall Street Journal is pressing the Securities and Exchange Commission for records involving Trump-affiliated 1789 Capital – a timely request after a...
by John A. Jenkins | Jul 17, 2025 | FDA, FOIA, Hedge Funds, Stock Market
FOIAengine: How a Proxy Requester Masks Its Identity On April 14, 2021, online forums where retail investors and short sellers exchange research, rumors, and trading strategies were buzzing. On Reddit and Twitter, meme stock traders were watching for the next big...
by John A. Jenkins | Jul 9, 2025 | FDA, FOIA, Hedge Funds, Stock Market
FOIAengine: Decoding How a Hedge Fund Tracks FDA Requests ExodusPoint burst onto the hedge fund scene in 2018 with the largest launch in history — raising $8.5 billion out of the gate — powered by institutional backing, an elite Wall Street pedigree, and high-profile...
